Jefferies Starts Moderna (MRNA) at Hold

December 12, 2025 12:59 AM EST Send to a Friend
Jefferies analyst Andrew Tsai initiates coverage on Moderna (NASDAQ: MRNA) with a Hold rating and a price target of $30.00.The ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login